Development of hairy cell leukemia in a patient treated with cytoreductive agents for essential thrombocythemia.

Abstract

The association of second malignancies in hairy cell leukemia (HCL) is well recognized. Most of these malignancies are either solid tumors or lymphoproliferative disorders rather than myeloproliferative disorders. But these malignancies are usually related to a complication of the drug treatment for HCL. The chronological sequence of HCL occurring after a… (More)

Topics

  • Presentations referencing similar topics